|
1
|
Farris AB and Colvin RB: Renal
interstitial fibrosis: Mechanisms and evaluation. Curr Opin Nephrol
Hypertens. 21:289–300. 2012. View Article : Google Scholar
|
|
2
|
Zeisberg M and Neilson EG: Mechanisms of
tubulointerstitial fibrosis. J Am Soc Nephrol. 21:1819–1834. 2010.
View Article : Google Scholar
|
|
3
|
Duffield JS: Cellular and molecular
mechanisms in kidney fibrosis. J Clin Invest. 124:2299–2306. 2014.
View Article : Google Scholar
|
|
4
|
Strutz F and Zeisberg M: Renal fibroblasts
and myofibroblasts in chronic kidney disease. J Am Soc Nephrol.
17:2992–2998. 2006. View Article : Google Scholar
|
|
5
|
Sun YB, Qu X, Caruana G and Li J: The
origin of renal fibroblasts/myofibroblasts and the signals that
trigger fibrosis. Differentiation. 92:102–107. 2016. View Article : Google Scholar
|
|
6
|
Asada N, Takase M, Nakamura J, Oguchi A,
Asada M, Suzuki N, Yamamura K, Nagoshi N, Shibata S, Rao TN, et al:
Dysfunction of fibroblasts of extrarenal origin underlies renal
fibrosis and renal anemia in mice. J Clin Invest. 121:3981–3990.
2011. View
Article : Google Scholar
|
|
7
|
Li X and Zhuang S: Recent advances in
renal interstitial fibrosis and tubular atrophy after kidney
transplantation. Fibrogenesis Tissue Repair. 7:152014. View Article : Google Scholar
|
|
8
|
Han HI, Skvarca LB, Espiritu EB, Davidson
AJ and Hukriede NA: The role of macrophages during acute kidney
injury: Destruction and repair. Pediatr Nephrol. 2018. View Article : Google Scholar
|
|
9
|
Cao Q, Harris DC and Wang Y: Macrophages
in kidney injury, inflammation, and fibrosis. Physiology
(Bethesda). 30:183–194. 2015.
|
|
10
|
Yonemoto S, Machiguchi T, Nomura K,
Minakata T, Nanno M and Yoshida H: Correlations of tissue
macrophages and cytoskeletal protein expression with renal fibrosis
in patients with diabetes mellitus. Clin Exp Nephrol. 10:186–192.
2006. View Article : Google Scholar
|
|
11
|
Chevalier RL, Forbes MS and Thornhill BA:
Ureteral obstruction as a model of renal interstitial fibrosis and
obstructive nephropathy. Kidney Int. 75:1145–1152. 2009. View Article : Google Scholar
|
|
12
|
Wang M, Liu R, Jia X, Mu S and Xie R:
N-acetyl-seryl-aspartyllysyl-proline attenuates renal inflammation
and tubulointerstitial fibrosis in rats. Int J Mol Med. 26:795–801.
2010.
|
|
13
|
Diamond JR: Macrophages and progressive
renal disease in experimental hydronephrosis. Am J Kidney Dis.
26:133–140. 1995. View Article : Google Scholar
|
|
14
|
Kitamoto K, Machida Y, Uchida J, Izumi Y,
Shiota M, Nakao T, Iwao H, Yukimura T, Nakatani T and Miura K:
Effects of liposome clodronate on renal leukocyte populations and
renal fibrosis in murine obstructive nephropathy. J Pharmacol Sci.
111:285–292. 2009. View Article : Google Scholar
|
|
15
|
Eis V, Luckow B, Vielhauer V, Siveke JT,
Linde Y, Segerer S, Perez De Lema G, Cohen CD, Kretzler M, Mack M,
et al: Chemokine receptor CCR1 but not CCR5 mediates leukocyte
recruitment and subsequent renal fibrosis after unilateral ureteral
obstruction. J Am Soc Nephrol. 15:337–347. 2004. View Article : Google Scholar
|
|
16
|
Kitagawa K, Wada T, Furuichi K, Hashimoto
H, Ishiwata Y, Asano M, Takeya M, Kuziel WA, Matsushima K, Mukaida
N and Yokoyama H: Blockade of CCR2 ameliorates progressive fibrosis
in kidney. Am J Pathol. 165:237–246. 2004. View Article : Google Scholar
|
|
17
|
MacKinnon AC, Farnworth SL, Hodkinson PS,
Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes
SJ and Sethi T: Regulation of alternative macrophage activation by
galectin-3. J Immunol. 180:2650–2658. 2008. View Article : Google Scholar
|
|
18
|
Henderson NC, Mackinnon AC, Farnworth SL,
Kipari T, Haslett C, Iredale JP, Liu FT, Hughes J and Sethi T:
Galectin-3 expression and secretion links macrophages to the
promotion of renal fibrosis. Am J Pathol. 172:288–298. 2008.
View Article : Google Scholar
|
|
19
|
Hugo C and Daniel C: Thrombospondin in
renal disease. Nephron Exp Nephrol. 111:e61-e662009. View Article : Google Scholar
|
|
20
|
Wynes MW, Frankel SK and Riches DW:
IL-4-induced macrophage-derived IGF-I protects myofibroblasts from
apoptosis following growth factor withdrawal. J Leukoc Biol.
76:1019–1027. 2004. View Article : Google Scholar
|
|
21
|
Lin SL and Kisseleva T: Pericytes and
perivascular fibroblasts are the primary source of
collagen-producing cells in obstructive fibrosis of the kidney. Am
J Pathol. 173:1617–1627. 2008. View Article : Google Scholar
|
|
22
|
Mori R, Shaw TJ and Martin P: Molecular
mechanisms linking wound inflammation and fibrosis: Knockdown of
osteopontin leads to rapid repair and reduced scarring. J Exp Med.
205:43–51. 2008. View Article : Google Scholar
|
|
23
|
Chujo S, Shirasaki F, Kondo-Miyazaki M,
Ikawa Y and Takehara K: Role of connective tissue growth factor and
its interaction with basic fibroblast growth factor and macrophage
chemoattractant protein-1 in skin fibrosis. J Cell Physiol.
220:189–195. 2009. View Article : Google Scholar
|
|
24
|
Zhao YY, Yan DJ and Chen ZW: Role of AIF-1
in the regulation of inflammatory activation and diverse disease
processes. Cell Immunol. 284:75–83. 2013. View Article : Google Scholar
|
|
25
|
Utans U, Arceci RJ, Yamashita Y and
Russell ME: Cloning and characterization of allograft inflammatory
factor-1: A novel macrophage factor identified in rat cardiac
allografts with chronic rejection. J Clin Invest. 95:2954–2962.
1995. View Article : Google Scholar
|
|
26
|
Utans U, Quist WC, McManus BM, Wilson JE,
Arceci RJ, Wallace AF and Russell ME: Allograft inflammatory
factory-1. A cytokine-responsive macrophage molecule expressed in
transplanted human hearts. Transplantation. 61:1387–1392. 1996.
View Article : Google Scholar
|
|
27
|
Imai Y, Ibata I, Ito D, Ohsawa K and
Kohsaka S: A novel gene iba1 in the major histocompatibility
complex class III region encoding an EF hand protein expressed in a
monocytic lineage. Biochem Biophys Res Commun. 224:855–862. 1996.
View Article : Google Scholar
|
|
28
|
Tanaka S, Suzuki K, Watanabe M, Matsuda A,
Tone S and Koike T: Upregulation of a new microglial gene, mrf-1,
in response to programmed neuronal cell death and degeneration. J
Neurosci. 18:6358–6369. 1998. View Article : Google Scholar
|
|
29
|
Chen ZW, Ahren B, Ostenson CG, Cintra A,
Bergman T, Möller C, Fuxe K, Mutt V, Jörnvall H and Efendic S:
Identification, isolation, and characterization of daintain
(allograft inflammatory factor 1), a macrophage polypeptide with
effects on insulin secretion and abundantly present in the pancreas
of prediabetic BB rats. Proc Natl Acad Sci USA. 94:13879–13884.
1997. View Article : Google Scholar
|
|
30
|
Tian Y, Kelemen SE and Autieri MV:
Inhibition of AIF-1 expression by constitutive siRNA expression
reduces macrophage migration, proliferation, and signal
transduction initiated by atherogenic stimuli. Am J Physiol Cell
Physiol. 290:C1083–C1091. 2006. View Article : Google Scholar
|
|
31
|
Watano K, Iwabuchi K, Fujii S, Ishimori N,
Mitsuhashi S, Ato M, Kitabatake A and Onoé K: Allograft
inflammatory factor-1 augments production of interleukin-6, -10 and
-12 by a mouse macrophage line. Immunology. 104:307–316. 2001.
View Article : Google Scholar
|
|
32
|
Yang ZF, Ho DW, Lau CK, Lam CT, Lum CT,
Poon RT and Fan ST: Allograft inflammatory factor-1 (AIF-1) is
crucial for the survival and pro-inflammatory activity of
macrophages. Int Immunol. 17:1391–1397. 2005. View Article : Google Scholar
|
|
33
|
Kadoya M, Yamamoto A, Hamaguchi M,
Obayashi H, Mizushima K, Ohta M, Seno T, Oda R, Fujiwara H, Kohno M
and Kawahito Y: Allograft inflammatory factor-1 stimulates
chemokine production and induces chemotaxis in human peripheral
blood mononuclear cells. Biochem Biophys Res Commun. 448:287–291.
2014. View Article : Google Scholar
|
|
34
|
Mishima T, Iwabuchi K, Fujii S, Tanaka SY,
Ogura H, Watano-Miyata K, Ishimori N, Andoh Y, Nakai Y, Iwabuchi C,
et al: Allograft inflammatory factor-1 augments macrophage
phagocytotic activity and accelerates the progression of
atherosclerosis in ApoE−/− mice. Int J Mol Med.
21:181–187. 2008.
|
|
35
|
Fukui M, Tanaka M, Asano M, Yamazaki M,
Hasegawa G, Imai S, Fujinami A, Ohta M, Obayashi H and Nakamura N:
Serum allograft inflammatory factor-1 is a novel marker for
diabetic nephropathy. Diabetes Res Clin Pract. 97:146–150. 2012.
View Article : Google Scholar
|
|
36
|
Chen QR, Guan F, Song SM, Jin JK, Lei DS,
Chen CM, Lei JH, Chen ZW and Niu AO: Allograft inflammatory
factor-1 alleviates liver disease of BALB/c mice infected with
Schistosoma japonicum. Parasitol Res. 113:2629–2639. 2014.
View Article : Google Scholar
|
|
37
|
Del Galdo F and Jimenez SA: T cells
expressing allograft inflammatory factor 1 display increased
chemotaxis and induce a profibrotic phenotype in normal fibroblasts
in vitro. Arthritis Rheum. 56:3478–3488. 2007. View Article : Google Scholar
|
|
38
|
Brown NJ: Contribution of aldosterone to
cardiovascular and renal inflammation and fibrosis. Nat Rev
Nephrol. 9:459–469. 2013. View Article : Google Scholar
|
|
39
|
Ranjit S, Dvornikov A, Levi M, Furgeson S
and Gratton E: Characterizing fibrosis in UUO mice model using
multiparametric analysis of phasor distribution from FLIM images.
Biomed Opt Express. 7:3519–3530. 2016. View Article : Google Scholar
|
|
40
|
Autieri MV, Carbone C and Mu A: Expression
of allograft inflammatory factor-1 is a marker of activated human
vascular smooth muscle cells and arterial injury. Arterioscler
Thromb Vasc Biol. 20:1737–1744. 2000. View Article : Google Scholar
|
|
41
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
42
|
Tsubata Y, Sakatsume M, Ogawa A, Alchi B,
Kaneko Y, Kuroda T, Kawachi H, Narita I, Yamamoto T and Gejyo F:
Expression of allograft inflammatory factor-1 in kidneys: A novel
molecular component of podocyte. Kidney Int. 70:1948–1954. 2006.
View Article : Google Scholar
|
|
43
|
Yamamoto A and Kawahito Y: The immunologic
function and role of allograft inflammatory factor-1. Nihon Rinsho
Meneki Gakkai Kaishi. 37:139–145. 2014.In Japanese. View Article : Google Scholar
|
|
44
|
Usher MG, Duan SZ, Ivaschenko CY, Frieler
RA, Berger S, Schutz G, Lumeng CN and Mortensen RM: Myeloid
mineralocorticoid receptor controls macrophage polarization and
cardiovascular hypertrophy and remodeling in mice. J Clin Invest.
120:3350–3364. 2010. View Article : Google Scholar
|
|
45
|
Sibinga NE, Feinberg MW, Yang H, Werner F
and Jain MK: Macrophage-restricted and interferon gamma-inducible
expression of the allograft inflammatory factor-1 gene requires
Pu.1. J Biol Chem. 277:16202–16210. 2002. View Article : Google Scholar
|
|
46
|
Cook HT: The origin of renal fibroblasts
and progression of kidney disease. Am J Pathol. 176:22–24. 2010.
View Article : Google Scholar
|
|
47
|
Grimm PC, McKenna R, Nickerson P, Russell
ME, Gough J, Gospodarek E, Liu B, Jeffery J and Rush DN: Clinical
rejection is distinguished from subclinical rejection by increased
infiltration by a population of activated macrophages. J Am Soc
Nephrol. 10:1582–1589. 1999.
|
|
48
|
McDaniel DO, Rigney DA, McDaniel KY,
Windham WJ, Redmond P, Williams B, Zhou X, Hawxby A and Butt F:
Early expression profile of inflammatory markers and kidney
allograft status. Transplant Proc. 45:1520–1523. 2013. View Article : Google Scholar
|
|
49
|
Vu D, Tellez-Corrales E, Shah T,
Hutchinson I and Min DI: Influence of Cyclooxygenase-2 (COX-2) gene
promoter-1195 and allograft inflammatory factor-1 (AIF-1)
polymorphisms on allograft outcome in Hispanic kidney transplant
recipients. Hum Immunol. 74:1386–1391. 2013. View Article : Google Scholar
|
|
50
|
Brauner A, Hertting O, Alkstrand E,
Sandberg E, Chromek M, Chen ZW and Ostenson CG: CAPD peritonitis
induces the production of a novel peptide, daintain/allograft
inflammatory factor-1. Perit Dial Int. 23:5–13. 2003.
|
|
51
|
Meng XM, Tang PM, Li J and Lan HY:
Macrophage phenotype in kidney injury and repair. Kidney Dis
(Basel). 1:138–146. 2015. View Article : Google Scholar
|
|
52
|
Nishida M, Okumura Y, Fujimoto S,
Shiraishi I, Itoi T and Hamaoka K: Adoptive transfer of macrophages
ameliorates renal fibrosis in mice. Biochem Biophys Res Commun.
332:11–16. 2005. View Article : Google Scholar
|
|
53
|
López-Guisa JM, Cai X, Collins SJ,
Yamaguchi I, Okamura DM, Bugge TH, Isacke CM, Emson CL, Turner SM,
Shankland SJ, et al: Mannose receptor 2 attenuates renal fibrosis.
J Am Soc Nephrol. 23:236–251. 2012. View Article : Google Scholar
|
|
54
|
Huen SC and Cantley LG: Macrophages in
Renal Injury and Repair. Annu Rev Physiol. 79:449–469. 2017.
View Article : Google Scholar
|
|
55
|
Tian L, Shao X, Xie Y, Wang Q, Che X,
Zhang M, Xu W, Xu Y, Mou S and Ni Z: Kidney injury molecule-1 is
elevated in nephropathy and mediates macrophage activation via the
Mapk signalling pathway. Cell Physiol Biochem. 41:769–783. 2017.
View Article : Google Scholar
|
|
56
|
Guiteras R, Sola A, Flaquer M, Hotter G,
Torras J, Grinyó JM and Cruzado JM: Macrophage overexpressing NGAL
ameliorated kidney fibrosis in the UUO mice model. Cell Physiol
Biochem. 42:1945–1960. 2017. View Article : Google Scholar
|
|
57
|
Xu Y, Yang S, Huang J, Ruan S, Zheng Z and
Lin J: Tgf-β1 induces autophagy and promotes apoptosis in renal
tubular epithelial cells. Int J Mol Med. 29:781–790. 2012.
|
|
58
|
Seystahl K, Papachristodoulou A, Burghardt
I, Schneider H, Hasenbach K, Janicot M, Roth P and Weller M:
Biological role and therapeutic targeting of TGF-β3 in
glioblastoma. Mol Cancer Ther. 16:1177–1186. 2017. View Article : Google Scholar
|
|
59
|
Vega G, Alarcon S and San Martín R: The
cellular and signalling alterations conducted by TGF-β contributing
to renal fibrosis. Cytokine. 88:115–125. 2016. View Article : Google Scholar
|
|
60
|
Yamamoto A, Ashihara E, Nakagawa Y,
Obayashi H, Ohta M, Hara H, Adachi T, Seno T, Kadoya M, Hamaguchi
M, et al: Allograft inflammatory factor-1 is overexpressed and
induces fibroblast chemotaxis in the skin of sclerodermatous GVHD
in a murine model. Immunol Lett. 135:144–150. 2011. View Article : Google Scholar
|
|
61
|
Del Galdo F, Maul GG, Jiménez SA and
Artlett CM: Expression of allograft inflammatory factor 1 in
tissues from patients with systemic sclerosis and in vitro
differential expression of its isoforms in response to transforming
growth factor beta. Arthritis Rheum. 54:2616–2625. 2006. View Article : Google Scholar
|
|
62
|
Hao L, Okada H, Kanno Y, Inoue T,
Kobayashi T, Watanabe Y, Strutz F, Müller GA and Suzuki H: Direct
contact between human peripheral blood mononuclear cells and renal
fibroblasts facilitates the expression of monocyte chemoattractant
protein-1. Am J Nephrol. 23:208–213. 2003. View Article : Google Scholar
|
|
63
|
Sommerville LJ, Kelemen SE and Autieri MV:
Increased smooth muscle cell activation and neointima formation in
response to injury in AIF-1 transgenic mice. Arterioscler Thromb
Vasc Biol. 28:47–53. 2008. View Article : Google Scholar
|
|
64
|
Tian Y, Jain S, Kelemen SE and Autieri MV:
AIF-1 expression regulates endothelial cell activation, signal
transduction, and vasculogenesis. Am J Physiol Cell Physiol.
296:C256–C266. 2009. View Article : Google Scholar
|
|
65
|
McCaskill JL, Ressel S, Alber A, Redford
J, Power UF, Schwarze J, Dutia BM and Buck AH: Broad-spectrum
inhibition of respiratory virus infection by MicroRNA mimics
targeting p38 MAPK signaling. Mol Ther Nucleic Acids. 7:256–266.
2017. View Article : Google Scholar
|
|
66
|
Wang D, Warner GM, Yin P, Knudsen BE,
Cheng J, Butters KA, Lien KR, Gray CE, Garovic VD, Lerman LO, et
al: Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in
a murine renal artery stenosis model. Am J Physiol Renal Physiol.
304:F938–F947. 2013. View Article : Google Scholar
|
|
67
|
Huang JS, Chuang CT, Liu MH, Lin SH, Guh
JY and Chuang LY: Klotho attenuates high glucose-induced
fibronectin and cell hypertrophy via the ERK1/2-p38 kinase
signaling pathway in renal interstitial fibroblasts. Mol Cell
Endocrinol. 390:45–53. 2014. View Article : Google Scholar
|
|
68
|
Blasi ER, Rocha R, Rudolph AE, Blomme EA,
Polly ML and McMahon EG: Aldosterone/salt induces renal
inflammation and fibrosis in hypertensive rats. Kidney Int.
63:1791–1800. 2003. View Article : Google Scholar
|
|
69
|
Kadoya H, Satoh M, Sasaki T, Taniguchi S,
Takahashi M and Kashihara N: Excess aldosterone is a critical
danger signal for inflammasome activation in the development of
renal fibrosis in mice. FASEB J. 29:3899–3910. 2015. View Article : Google Scholar
|
|
70
|
Bengough AG, Hans J, Bransby MF and
Valentine TA: PIV as a method for quantifying root cell growth and
particle displacement in confocal images. Microsc Res Tech.
73:27–36. 2010.
|
|
71
|
Nagahara H, Yamamoto A, Seno T, Obayashi
H, Kida T, Nakabayashi A, Kukida Y, Fujioka K, Fujii W, Murakami K,
et al: Allograft inflammatory factor-1 in the pathogenesis of
bleomycin-induced acute lung injury. Biosci Trends. 10:47–53. 2016.
View Article : Google Scholar
|
